Shen Qiang, Yao Dingyi, Zhao Yang, Qian Xingyu, Zheng Yidan, Xu Li, Jiang Chen, Zheng Qiang, Chen Si, Shi Jiawei, Dong Nianguo
Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Organ Transplantation, Ministry of Education, Wuhan, China.
Front Cardiovasc Med. 2023 Sep 7;10:1210278. doi: 10.3389/fcvm.2023.1210278. eCollection 2023.
The purpose of this study was to investigate the prognostic significance of serum albumin to creatinine ratio (ACR) in patients receiving heart transplantation of end-stage heart failure.
From January 2015 to December 2020, a total of 460 patients who underwent heart transplantation were included in this retrospective analysis. According to the maximum Youden index, the optimal cut-off value was identified. Kaplan-Meier methods were used to describe survival rates, and multivariable analyses were conducted with Cox proportional hazard models. Meanwhile, logistic regression analysis was applied to evaluate predictors for postoperative complications. The accuracy of risk prediction was evaluated by using the concordance index (C-index) and calibration plots.
The optimal cut-off value was 37.54 for ACR. Univariable analysis indicated that recipient age, IABP, RAAS, BB, Hb, urea nitrogen, D-dimer, troponin, TG, and ACR were significant prognostic factors of overall survival (OS). Multivariate analysis showed that preoperative ACR (HR: 0.504, 95% = 0.352-0.722, < 0.001) was still an independent prognostic factor of OS. The nomogram for predicting 1-year and 5-year OS in patients who underwent heart transplantation without ACR (C-index = 0.631) and with ACR (C-index = 0.671). Besides, preoperative ACR level was a significant independent predictor of postoperative respiratory complications, renal complications, liver injury, infection and in-hospital death. Moreover, the calibration plot showed good consistency between the predictions by the nomogram for OS and the actual outcomes.
Our research showed that ACR is a favorable prognostic indicator in patients of heart transplantation.
本研究旨在探讨血清白蛋白与肌酐比值(ACR)在终末期心力衰竭心脏移植患者中的预后意义。
2015年1月至2020年12月,共有460例接受心脏移植的患者纳入本回顾性分析。根据最大约登指数确定最佳截断值。采用Kaplan-Meier方法描述生存率,并使用Cox比例风险模型进行多变量分析。同时,应用逻辑回归分析评估术后并发症的预测因素。通过一致性指数(C-index)和校准图评估风险预测的准确性。
ACR的最佳截断值为37.54。单变量分析表明,受者年龄、主动脉内球囊反搏(IABP)、肾素-血管紧张素-醛固酮系统(RAAS)抑制剂、β受体阻滞剂(BB)、血红蛋白(Hb)、尿素氮、D-二聚体、肌钙蛋白、甘油三酯(TG)和ACR是总生存(OS)的显著预后因素。多变量分析显示,术前ACR(风险比:0.504,95%置信区间=0.352-0.722,P<0.001)仍是OS的独立预后因素。预测未纳入ACR和纳入ACR的心脏移植患者1年和5年OS的列线图(C-index分别为0.631和0.671)。此外,术前ACR水平是术后呼吸并发症、肾脏并发症、肝损伤、感染和院内死亡的显著独立预测因素。而且,校准图显示OS列线图预测结果与实际结果之间具有良好的一致性。
我们的研究表明,ACR是心脏移植患者的良好预后指标。